VHT Vanguard Health Care ETF
Quote as of Aug 26, 2026 20:00 UTC · Market data delayed approximately 15–20 minutes unless otherwise indicated.
| Previous Close | 329.01 | Day Range | 325.83 – 328.09 |
| 52-Week Range | 249.57 – 330.75 | Volume | 279.58K |
| Avg Volume | 238.32K | AUM | $20.90B (Aug 27, 2026) |
| Expense Ratio | 0.09% | Yield (TTM) | 1.44% |
| NAV | 326.13 | Premium/Discount | +0.04% indicative |
| Inception | Jan 26, 2004 | Holdings | 411 |
| Issuer | Vanguard | Exchange | AMEX |
| Category | Healthcare | Index Tracked | Not stated in source data |
| CUSIP | 92204A504 | ISIN | US92204A5048 |
| Management | Not stated in source data | ||
About this ETF
This exchange-traded fund endeavors to replicate the financial outcomes of a designated benchmark index, which assesses the investment appreciation of equities within the healthcare sector. It operates under a passive management style, generally utilizing a full replication strategy; however, a sampling approach may be adopted when necessitated by regulatory requirements. The fund's portfolio is comprised of shares from enterprises engaged in providing medical or health-related goods, services, technological innovations, or equipment.
Description from the fund data provider · profile as of Aug 27, 2026.
Price Chart
Daily closing prices (price return, not total return). Comparison lines are normalized to percent change from the range start. Source: Financial Modeling Prep.
Performance
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Incep.* | |
|---|---|---|---|---|---|---|---|---|---|
| Price return | +7.85% | +18.64% | +12.70% | +14.30% | +30.23% | +10.43% | +4.78% | +9.42% | +8.70% |
| Total return | +7.85% | +19.05% | +13.51% | +15.12% | +32.48% | +12.15% | +6.34% | +11.05% | +10.24% |
* Annualized. Total return uses the dividend-adjusted price series (distributions reinvested); price return uses unadjusted closes. Performance through Aug 25, 2026. Past performance does not guarantee future results.
Fees
| Net expense ratio | 0.09% | Annual cost of a $10,000 investment | $9.00 |
Illustrative calculation only: expense ratio × $10,000. It excludes trading costs, bid/ask spreads, taxes and changes in investment value. Gross vs. net expense details and any fee waivers are in the prospectus.
Holdings
Holdings as of Aug 25, 2026 — portfolio reporting date from the data provider; holdings are not live positions. 421 rows in database.
| # | Holding | Ticker | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | LLY | 13.40% | 2.44M | $2.80B |
| 2 | Johnson & Johnson | JNJ | 8.84% | 7.22M | $1.85B |
| 3 | AbbVie Inc | ABBV | 6.45% | 5.37M | $1.35B |
| 4 | UnitedHealth Group Inc | UNH | 5.46% | 2.76M | $1.14B |
| 5 | Merck & Co Inc | MRK | 4.67% | 7.51M | $978.1M |
| 6 | Thermo Fisher Scientific Inc | TMO | 3.10% | 1.13M | $648.5M |
| 7 | Amgen Inc | AMGN | 3.01% | 1.64M | $630.8M |
| 8 | Abbott Laboratories | ABT | 2.67% | 5.29M | $559.3M |
| 9 | Gilead Sciences Inc | GILD | 2.35% | 3.77M | $491.1M |
| 10 | Pfizer Inc | PFE | 2.07% | 17.28M | $432.3M |
| 11 | Bristol-Myers Squibb Co | BMY | 1.94% | 6.20M | $405.2M |
| 12 | CVS Health Corp | CVS | 1.93% | 3.87M | $403.7M |
| 13 | Intuitive Surgical Inc | ISRG | 1.82% | 1.08M | $381.3M |
| 14 | Danaher Corp | DHR | 1.80% | 1.94M | $377.3M |
| 15 | Vertex Pharmaceuticals Inc | VRTX | 1.76% | 772.90K | $368.8M |
| 16 | Stryker Corp | SYK | 1.63% | 1.05M | $341.1M |
| 17 | Medtronic PLC | MDT | 1.59% | 3.90M | $333.1M |
| 18 | McKesson Corp | MCK | 1.52% | 372.15K | $318.6M |
| 19 | Elevance Health Inc | ELV | 1.17% | 653.10K | $245.5M |
| 20 | Regeneron Pharmaceuticals Inc | REGN | 1.15% | 315.73K | $240.8M |
| 21 | Cigna Group/The | CI | 1.07% | 801.18K | $223.6M |
| 22 | Boston Scientific Corp | BSX | 1.01% | 4.52M | $211.0M |
| 23 | HCA Healthcare Inc | HCA | 0.91% | 475.53K | $191.4M |
| 24 | Cencora Inc | COR | 0.84% | 561.46K | $174.8M |
| 25 | Cardinal Health Inc | CAH | 0.79% | 714.92K | $164.5M |
Click a ticker to see every ETF that owns it.
Sector Exposure
Geographic Exposure
Country weights as reported by the data provider. Developed/emerging/frontier labels follow the classification on the Methodology page. Currency hedged: No hedging indicated in the fund name.
Distributions
| Yield (TTM) | 1.44% | Paid (last 12 months) | $4.7227 |
| Frequency | Quarterly | SEC yield | Not provided by our data source — see the issuer page |
| Last ex-date | Jun 24, 2026 | Last payment | $0.9868 (Jun 26, 2026) |
| Growth 1Y | +18.45% | Growth 3Y / 5Y (ann.) | +11.17% / +10.65% |
| Ex-date | Record | Pay date | Amount |
|---|---|---|---|
| Jun 24, 2026 | Jun 24, 2026 | Jun 26, 2026 | $0.9868 |
| Mar 24, 2026 | Mar 24, 2026 | Mar 26, 2026 | $0.9940 |
| Dec 17, 2025 | Dec 17, 2025 | Dec 19, 2025 | $1.6654 |
| Sep 24, 2025 | Sep 24, 2025 | Sep 26, 2025 | $1.0765 |
| Jun 26, 2025 | Jun 26, 2025 | Jun 30, 2025 | $0.9619 |
| Mar 25, 2025 | Mar 25, 2025 | Mar 27, 2025 | $0.9396 |
| Dec 18, 2024 | Dec 18, 2024 | Dec 20, 2024 | $0.9188 |
| Sep 27, 2024 | Sep 27, 2024 | Oct 01, 2024 | $1.1666 |
| Jun 28, 2024 | Jun 28, 2024 | Jul 02, 2024 | $0.9656 |
| Mar 22, 2024 | Mar 25, 2024 | Mar 27, 2024 | $0.8189 |
| Dec 19, 2023 | Dec 20, 2023 | Dec 22, 2023 | $0.8947 |
| Sep 28, 2023 | Sep 29, 2023 | Oct 03, 2023 | $0.8774 |
Trailing distribution yield = last 12 months of cash ÷ current price. It is NOT the SEC 30-day yield and distributions are not guaranteed to continue. The difference explained →
Risk Statistics
| Volatility 1Y / 3Y | 15.36% / 14.62% | Sharpe 1Y / 3Y | 1.98 / 0.665 |
| Max drawdown 1Y / 3Y | -10.40% / -16.91% | Sortino 1Y | 3.42 |
| Beta vs S&P 500 (3Y) | 0.503 | Correlation vs S&P 500 (1Y) | 0.29 |
| Downside deviation 1Y | 8.92% | Risk-free rate used | 3.72% (3M T-bill, FRED) |
Computed by ETF Explorer from daily dividend-adjusted closes; volatility and drawdown are annualized/period figures; S&P 500 exposure proxied by SPY. As of Aug 26, 2026. Formulas →
Liquidity
| Volume today | 279.58K | Average volume | 238.32K |
| AUM | $20.90B | Premium/Discount | +0.04% |
| Bid/Ask spread | Not provided by our data source. Check your broker's quote screen; spreads are widest at the open and close. | ||
Premium/discount compares the delayed market price with the last reported NAV — an indicative figure, not the official closing premium/discount. How ETF liquidity works →
Fund Flows (estimated)
| Period | Est. net flow | % of starting AUM | AUM start → end |
|---|---|---|---|
| 1 Day | $0.00 | 0.00% | $20.90B → $20.90B |
| 1 Week | $29.8M | +0.14% | $20.90B → $20.90B |
ETF Explorer estimate: change in reported AUM minus the market-move effect, from our own daily snapshots. Not official issuer creation/redemption data.
Official Fund Resources
External links open the issuer's site or SEC EDGAR in a new tab. The prospectus and official documents are always the authoritative source — review them before investing.
Latest News for VHT
No articles mention this fund directly in the last 7 days — showing general ETF coverage.
Guided help: AUM is fund size. The expense ratio is the yearly cost baked into returns. NAV is the value of what the fund owns per share; the market price can sit slightly above (premium) or below (discount) it. Total return assumes distributions were reinvested. Every dataset shows its own as-of date because holdings, assets and quotes update on different schedules.